Literature DB >> 12549483

Hereditary p16-Leiden mutation in a patient with multiple head and neck tumors.

Regine Schneider-Stock, Anja Giers, Christiane Motsch, Carsten Boltze, Matthias Evert, Bernd Freigang, Albert Roessner.   

Abstract

Entities:  

Mesh:

Year:  2003        PMID: 12549483      PMCID: PMC378629          DOI: 10.1086/345397

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


× No keyword cloud information.
  13 in total

1.  Phenotypic variation in eight extended CDKN2A germline mutation familial atypical multiple mole melanoma-pancreatic carcinoma-prone families: the familial atypical mole melanoma-pancreatic carcinoma syndrome.

Authors:  Henry T Lynch; Randall E Brand; David Hogg; Carolyn A Deters; Ramon M Fusaro; Jane F Lynch; Ling Liu; Joseph Knezetic; Norman J Lassam; Michael Goggins; Scott Kern
Journal:  Cancer       Date:  2002-01-01       Impact factor: 6.860

2.  Somatic INK4a-ARF locus mutations: a significant mechanism of gene inactivation in squamous cell carcinomas of the head and neck.

Authors:  M J Poi; T Yen; J Li; H Song; J C Lang; D E Schuller; D K Pearl; B C Casto; M D Tsai; C M Weghorst
Journal:  Mol Carcinog       Date:  2001-01       Impact factor: 4.784

3.  Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion of p16 (p16-Leiden).

Authors:  H F Vasen; N A Gruis; R R Frants; P A van Der Velden; E T Hille; W Bergman
Journal:  Int J Cancer       Date:  2000-09-15       Impact factor: 7.396

4.  Promoter hypermethylation patterns of p16, O6-methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients.

Authors:  S L Rosas; W Koch; M G da Costa Carvalho; L Wu; J Califano; W Westra; J Jen; D Sidransky
Journal:  Cancer Res       Date:  2001-02-01       Impact factor: 12.701

5.  Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer.

Authors:  W M Grady; J Willis; P J Guilford; A K Dunbier; T T Toro; H Lynch; G Wiesner; K Ferguson; C Eng; J G Park; S J Kim; S Markowitz
Journal:  Nat Genet       Date:  2000-09       Impact factor: 38.330

6.  A locus linked to p16 modifies melanoma risk in Dutch familial atypical multiple mole melanoma (FAMMM) syndrome families.

Authors:  P A van der Velden; L A Sandkuijl; W Bergman; E T Hille; R R Frants; N A Gruis
Journal:  Genome Res       Date:  1999-06       Impact factor: 9.043

7.  Patients with both pancreatic adenocarcinoma and melanoma may harbor germline CDKN2A mutations.

Authors:  G Lal; L Liu; D Hogg; N J Lassam; M S Redston; S Gallinger
Journal:  Genes Chromosomes Cancer       Date:  2000-04       Impact factor: 5.006

8.  Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.

Authors:  J G Herman; J R Graff; S Myöhänen; B D Nelkin; S B Baylin
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

9.  Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindreds.

Authors:  N A Gruis; P A van der Velden; L A Sandkuijl; D E Prins; J Weaver-Feldhaus; A Kamb; W Bergman; R R Frants
Journal:  Nat Genet       Date:  1995-07       Impact factor: 38.330

10.  Gene alterations at the CDKN2A (p16/MTS1) locus in soft tissue tumors.

Authors:  R Schneider-Stock; H Walter; C Haeckel; K Radig; J Rys; A Roessner
Journal:  Int J Oncol       Date:  1998-08       Impact factor: 5.650

View more
  7 in total

1.  [Hereditary head and neck tumors].

Authors:  S Schwarz-Furlan; C Brase; P Stockmann; I Furlan; A Hartmann
Journal:  Pathologe       Date:  2010-10       Impact factor: 1.011

2.  A common variant of CDKN2A (p16) predisposes to breast cancer.

Authors:  T Debniak; B Górski; T Huzarski; T Byrski; C Cybulski; A Mackiewicz; S Gozdecka-Grodecka; J Gronwald; E Kowalska; O Haus; E Grzybowska; M Stawicka; M Swiec; K Urbański; S Niepsuj; B Waśko; S Góźdź; P Wandzel; C Szczylik; D Surdyka; A Rozmiarek; O Zambrano; M Posmyk; S A Narod; J Lubinski
Journal:  J Med Genet       Date:  2005-05-06       Impact factor: 6.318

3.  p16INK4A alterations are accompanied by aberrant protein immunostaining in endometrial carcinomas.

Authors:  Andrzej Semczuk; Carsten Boltze; Barbara Marzec; Anna Szczygielska; Albert Roessner; Regine Schneider-Stock
Journal:  J Cancer Res Clin Oncol       Date:  2003-08-14       Impact factor: 4.553

4.  Unraveling the molecular genetics of head and neck cancer through genome-wide approaches.

Authors:  Nadeem Riaz; Luc G Morris; William Lee; Timothy A Chan
Journal:  Genes Dis       Date:  2014-09

Review 5.  CDKN2A germline alterations and the relevance of genotype-phenotype associations in cancer predisposition.

Authors:  Sock Hoai Chan; Jianbang Chiang; Joanne Ngeow
Journal:  Hered Cancer Clin Pract       Date:  2021-03-25       Impact factor: 2.857

6.  Hereditary oral squamous cell carcinoma associated with CDKN2A germline mutation: a case report.

Authors:  Ah-Reum Jeong; Kimberly Forbes; Ryan K Orosco; Ezra E W Cohen
Journal:  J Otolaryngol Head Neck Surg       Date:  2022-02-05

7.  Some molecular and clinical aspects of genetic predisposition to malignant melanoma and tumours of various site of origin.

Authors:  Tadeusz Debniak
Journal:  Hered Cancer Clin Pract       Date:  2007-06-15       Impact factor: 2.857

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.